1. Home
  2. RCEL vs GDO Comparison

RCEL vs GDO Comparison

Compare RCEL & GDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCEL
  • GDO
  • Stock Information
  • Founded
  • RCEL N/A
  • GDO 2009
  • Country
  • RCEL United States
  • GDO United States
  • Employees
  • RCEL N/A
  • GDO N/A
  • Industry
  • RCEL Medical/Dental Instruments
  • GDO Finance Companies
  • Sector
  • RCEL Health Care
  • GDO Finance
  • Exchange
  • RCEL Nasdaq
  • GDO Nasdaq
  • Market Cap
  • RCEL 107.8M
  • GDO 89.6M
  • IPO Year
  • RCEL N/A
  • GDO N/A
  • Fundamental
  • Price
  • RCEL $3.42
  • GDO $11.53
  • Analyst Decision
  • RCEL Buy
  • GDO
  • Analyst Count
  • RCEL 5
  • GDO 0
  • Target Price
  • RCEL $11.80
  • GDO N/A
  • AVG Volume (30 Days)
  • RCEL 260.2K
  • GDO 39.4K
  • Earning Date
  • RCEL 11-06-2025
  • GDO 01-01-0001
  • Dividend Yield
  • RCEL N/A
  • GDO 9.81%
  • EPS Growth
  • RCEL N/A
  • GDO N/A
  • EPS
  • RCEL N/A
  • GDO N/A
  • Revenue
  • RCEL $74,884,000.00
  • GDO N/A
  • Revenue This Year
  • RCEL $20.40
  • GDO N/A
  • Revenue Next Year
  • RCEL $32.94
  • GDO N/A
  • P/E Ratio
  • RCEL N/A
  • GDO N/A
  • Revenue Growth
  • RCEL 38.32
  • GDO N/A
  • 52 Week Low
  • RCEL $3.37
  • GDO $11.21
  • 52 Week High
  • RCEL $14.16
  • GDO $13.04
  • Technical
  • Relative Strength Index (RSI)
  • RCEL 28.06
  • GDO 34.50
  • Support Level
  • RCEL $3.88
  • GDO $11.50
  • Resistance Level
  • RCEL $3.91
  • GDO $11.90
  • Average True Range (ATR)
  • RCEL 0.23
  • GDO 0.13
  • MACD
  • RCEL -0.05
  • GDO -0.02
  • Stochastic Oscillator
  • RCEL 0.00
  • GDO 6.82

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

About GDO Western Asset Global Corporate Defined Opportunity Fund Inc.

Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.

Share on Social Networks: